Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intermittent vs Continuous Androgen Deprivation in Advanced Prostate Cancer
NCT00293670Phase 4Unknown
- Sponsor
- Tampere University
- Start
- May 1997
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of goserelin in prostate cancer (PCa), sponsored by Tampere University. Status: unknown.
02
Drugs
goserelin
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00293670.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00293670.